Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up After Dividend Announcement

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) gapped up prior to trading on Tuesday after the company announced a dividend. The stock had previously closed at $4.59, but opened at $5.02. Hypermarcas shares last traded at $5.02, with a volume of 25,000 shares changing hands.

The newly announced dividend which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be issued a $0.0345 dividend. The ex-dividend date is Monday, June 30th. This represents a dividend yield of 2.81%. Hypermarcas's payout ratio is 45.83%.

Hypermarcas Stock Performance

The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80. The stock has a 50-day moving average price of $4.30 and a 200-day moving average price of $3.60. The company has a market capitalization of $3.01 billion, a price-to-earnings ratio of 19.79 and a beta of 0.79.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share for the quarter. Hypermarcas had a net margin of 12.51% and a return on equity of 6.95%. The business had revenue of $184.34 million during the quarter.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.